Cargando…
Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response
INTRODUCTION: Tocilizumab (TCZ), an anti-interleukin-6 receptor antibody, is clinically effective against rheumatoid arthritis (RA), and several reports have indicated how TCZ influences a number of mechanisms underlying RA pathogenesis. However, it is still unclear whether TCZ affects inflammatory...
Autores principales: | Kikuchi, Jun, Hashizume, Misato, Kaneko, Yuko, Yoshimoto, Keiko, Nishina, Naoshi, Takeuchi, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332922/ https://www.ncbi.nlm.nih.gov/pubmed/25604867 http://dx.doi.org/10.1186/s13075-015-0526-4 |
Ejemplares similares
-
Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)
por: Izumi, Keisuke, et al.
Publicado: (2015) -
Correction: Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)
por: Izumi, Keisuke, et al.
Publicado: (2016) -
Increased frequency of CD4(+)CD25(high) CD127(low/)(−) regulatory T cells in patients with multiple sclerosis
por: Khosravi, Maryam, et al.
Publicado: (2019) -
Peripheral CD4(+)CD25(hi)CD127(low) regulatory T cells are increased in patients with gastrointestinal cancer
por: Qiu, Junlan, et al.
Publicado: (2023) -
CD4(+)CD25(hi)CD127(low) Regulatory T Cells Are Increased in Oral Squamous Cell Carcinoma Patients
por: Lim, Kue Peng, et al.
Publicado: (2014)